health
Retrospective study links levetiracetam to longer survival in diffuse midline glioma
A Nature Medicine study links levetiracetam use with longer survival in children with diffuse midline glioma and reports reduced tumour growth in mouse models. The findings point to a tumour-selective effect on GABAergic neuron-to-glioma synapses and require prospective clinical testing.